Literature DB >> 5691689

Clinical experiences with compound 347, a halogenated anesthetic agent.

C Botty, B Brown, V Stanley, C R Stephen.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 5691689

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  6 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

2.  Clinical experiences with Ethrane in E.N.T. and oral surgery.

Authors:  R D Redfield
Journal:  Anesth Prog       Date:  1974 May-Jun

3.  Effect of Ethrane anaesthesia and surgical operation on adrenocortical function.

Authors:  T Oyama; A Matsuki; M Kudo
Journal:  Can Anaesth Soc J       Date:  1972-07

4.  Ventilation and chemoreflexes during enflurane sedation and anaesthesia in man.

Authors:  R L Knill; P H Manninen; J L Clement
Journal:  Can Anaesth Soc J       Date:  1979-09

5.  The influence of intravenous anaesthetics on enflurane-induced central nervous system seizure activity.

Authors:  P C Darimont; L C Jenkins
Journal:  Can Anaesth Soc J       Date:  1977-01

Review 6.  Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.

Authors:  Judith Aron-Wisnewsky; Chloé Vigliotti; Julia Witjes; Phuong Le; Adriaan G Holleboom; Joanne Verheij; Max Nieuwdorp; Karine Clément
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-09       Impact factor: 46.802
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.